-
Loading metrics
Open Access
Peer-reviewed
Research Article
Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer
-
Guan Wang,
Affiliation The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
⨯ -
Jing He,
Affiliation The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
⨯ -
Jianyun Zhao,
Affiliation The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
⨯ -
Wenting Yun,
Affiliation The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
⨯ -
Chengzhi Xie,
Affiliations The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, United States of America, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, United States of America
⨯ -
Jeffrey W. Taub,
Affiliations Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan, United States of America, Department of Pediatrics, Wayne State University School of Medicine, Detroit, Michigan, United States of America, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, United States of America
⨯ -
Asfar Azmi,
Affiliation Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, United States of America
⨯ -
Ramzi M. Mohammad,
Affiliation Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, United States of America
⨯ -
Yan Dong,
Affiliations The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China, Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, Louisiana, United States of America
⨯ -
Wei Kong,
Affiliations The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China, Key Laboratory for Molecular Enzymology and Engineering of the Ministry of Education, Jilin University, Changchun, China
⨯ -
Yingjie Guo ,
* E-mail: gey@karmanos.org (Y. Ge); guoyinjie@jlu.edu.cn (Y. Guo)
Affiliation The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China
⨯ -
Yubin Ge
* E-mail: gey@karmanos.org (Y. Ge); guoyinjie@jlu.edu.cn (Y. Guo)
Affiliations The State Engineering Laboratory of AIDS Vaccine, College of Life Science, Jilin University, Changchun, China, Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan, United States of America, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, United States of America
⨯
Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer
- Guan Wang,
- Jing He,
- Jianyun Zhao,
- Wenting Yun,
- Chengzhi Xie,
- Jeffrey W. Taub,
- Asfar Azmi,
- Ramzi M. Mohammad,
- Yan Dong,
- Wei Kong
- Published: December 14, 2012
- https://doi.org/10.1371/journal.pone.0052095